Boussard & Gavaudan Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,322
Closed -$2.51M 88
2023
Q3
$2.51M Sell
12,322
-45,664
-79% -$9.63M 0.29% 57
2023
Q2
$12M Buy
+57,986
New +$11.2M 1.14% 33
2022
Q2
Sell
-71,125
Closed -$16.4K 138
2022
Q1
$16.4K Sell
71,125
-57,645
-45% -$13.6M 2.15% 14
2021
Q4
$34.7M Sell
128,770
-6,323
-5% -$1.57M 3.02% 7
2021
Q3
$32.7K Hold
135,093
2.76% 7
2021
Q2
$31.7M Buy
+135,093
New +$30.8M 3.01% 9
2014
Q4
Sell
-2,762
Closed -$243K 83
2014
Q3
$243K Buy
+2,762
New +$250K 0.14% 77

Other funds holding LH

Boussard & Gavaudan Investment Management's LH Position: Q4 2023 in Review

Boussard & Gavaudan Investment Management sold out of Labcorp (LH) in Q4 2023, closing a stake of 12,322 shares — an estimated $2.51M sold.

Boussard & Gavaudan Investment Management first reported a position in LH in Q3 2014 and held it in 7 quarters. The position peaked at $34.7M in Q4 2021. 957 funds tracked by Wall St. Rank hold LH as of Q4 2023.

  • Boussard & Gavaudan Investment Management reported no remaining Labcorp position as of Q4 2023 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 12,322 Labcorp shares in Q4 2023, an estimated $2.51M.
  • Boussard & Gavaudan Investment Management first reported a position in Labcorp in Q3 2014 and held it in 7 quarters.
  • Boussard & Gavaudan Investment Management's Labcorp position peaked at $34.7M in Q4 2021.
  • 957 funds tracked by Wall St. Rank held Labcorp as of Q4 2023.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.